News About: Pharm. Affairs


Seoul Pharmaceutical Association, “Government must call off Veterinary Drug Monopolization Policy”

The Seoul Pharmaceutical Association presented a written statement that the extension of veterinary prescription drugs, which will help animal hospitals monopolize veterinary drugs and obstruct patients’ accessibility...

Abbvie announces acquisition of approval for chronic hepatitis C oral treatment VIEKIRAX/EXVIERA

Abbvie Korea(CEO Hong-Ki Yoo) announced the Korea Ministry of Health and Welfare approved VIEKIRAX(generic name: ombitasvir, paritaprevir, ritonavir) and EXVIERA(generic name: sasabuvir) as chronic hepatitis C treatme...

KVPA welcomes Zoetis’s decision to supply heartworm preventives to pharmacies

The Korea Veterinary Pharmacy Association(President Sung-Jin Kim, KVPA) expressed an opinion to welcome the Zoetis Korea’s decision to supply heartworm preventive medicines for pets.   This decision was followed by t...

1-year ‘satisfactory’ application of insurance benefit for Daklinza for treatment of hepatitis C

After the mass hepatitis C infection incident, the Korea Centers for Disease Control and Prevention(KCDC) recently revealed the reaction of Korean hepatitis C patients to interferon and the effect of treatment after a...

Why does KPA make fights against each other for the same goal?

As the Korean Pharmaceutical Association(KPA) has face continuous conflicts over the ‘improvement of election system’ issue at the regular representative meeting, the plan practically went vain, which raised strong cr...

National Assembly’s debate for adjustment of household drugs at convenient stores

While the government has created an issue as trying to adjust the number of emergency household products, it will conduct debates related to it. The National Assembly Health and Welfare Committee’s Rep. Do-Ja Choi(Pe...

KPDS, “Conditionally-approved Tasigna’s clinical trial result must be disclosed”

Korean Pharmacists for Democratic Society(KPDS) announced to make a request for disclosure of the clinical trial result of Novartis’ ‘Tasigna.’ Novartis acquired conditional approval for the Phase 3 clinical trial of...

New KPMA Chairman’s Quick movements

While its chairmen, executives and employees attended the inauguration of the 21st Korea Pharmaceutical Manufacturers Association(KPMA) Chairman on the last 2nd, Hee-Mok Won, the new chairman who started the 2-year te...

What are reasons why there have been a drought in new drug approval?

It seems it would be hard new drug developed by Korean pharmaceutical company to be commercialized this year, again. The Ministry of Food and Drug Safety anticipated 1 Korean new drug will acquire approval this year....

Korean pharma market encroached by overseas companies with imports increased by 19%

Last year, imports of pharmaceutical and cosmetic products were increased by 13.6% compared to the year before. Particularly, imports of finished drugs were enlarged by 19%, which shows the multinational pharmaceutic...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.